Literature DB >> 27941389

Factors modulating the inflammatory response in acute gouty arthritis.

Maartje C Cleophas1, Tania O Crişan, Leo A B Joosten.   

Abstract

PURPOSE OF REVIEW: Gout is a common debilitating form of arthritis and despite our extensive knowledge on the pathogenesis its prevalence is still rising quickly. In the current review, we provide a concise overview of recent discoveries in factors tuning the inflammatory response to soluble uric acid and monosodium urate crystals. RECENT
FINDINGS: It appears that soluble uric acid has a much larger role to play than just being a risk factor for gout. It may have widespread consequences for systemic inflammation and the development of metabolic syndrome. Additionally, a specific gout-related gut microbiome might not only provide us with a new diagnostic tool, but also highlights possible new therapeutic targets. Furthermore, several recent publications further elucidated the roles of mitochondrial dysfunction, production of reactive oxygen species, autophagy, and AMP-dependent protein kinase in monosodium urate-induced NLRP3 inflammasome activation. Finally, neutrophils have been shown to be involved in both the promotion and resolution of gouty inflammation. A new alpha-1-antitrypsin fusion protein may limit the proinflammatory effects of neutrophil-derived serine proteases.
SUMMARY: Together, these studies provide us with many new insights in the pathogenesis of gout, important new treatment targets, and a rationale to further study the role of soluble uric acid in inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27941389     DOI: 10.1097/BOR.0000000000000366

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  19 in total

1.  Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and/or high serum uric acid levels: a prospective cohort study.

Authors:  Iris J M Disveld; Sahel Zoakman; Tim L Th A Jansen; Gerard A Rongen; Laura B E Kienhorst; Hein J E M Janssens; Jaap Fransen; Matthijs Janssen
Journal:  Clin Rheumatol       Date:  2019-03-30       Impact factor: 2.980

2.  Coexistent Hyperuricemia and Gout in Rheumatoid Arthritis: Associations With Comorbidities, Disease Activity, and Mortality.

Authors:  Andrew Chiou; Bryant R England; Harlan Sayles; Geoffrey M Thiele; Michael J Duryee; Joshua F Baker; Namrata Singh; Grant W Cannon; Gail S Kerr; Andreas Reimold; Angelo Gaffo; Ted R Mikuls
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-06-07       Impact factor: 4.794

Review 3.  The role of mitochondria in rheumatic diseases.

Authors:  Yann L C Becker; Bhargavi Duvvuri; Paul R Fortin; Christian Lood; Eric Boilard
Journal:  Nat Rev Rheumatol       Date:  2022-09-29       Impact factor: 32.286

4.  Investigation of the Effects and Mechanisms of Dendrobium loddigesii Rolfe Extract on the Treatment of Gout.

Authors:  Kai-Hui Zhang; Mei-Qi Wang; Lu-Ling Wei; Cheng-Jing Feng; Yu-Si Zhang; Jian-Bei Teng
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-30       Impact factor: 2.629

Review 5.  Inflammatory Response to Regulated Cell Death in Gout and Its Functional Implications.

Authors:  Jianan Zhao; Kai Wei; Ping Jiang; Cen Chang; Lingxia Xu; Linshuai Xu; Yiming Shi; Shicheng Guo; Yu Xue; Dongyi He
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

Review 6.  What makes gouty inflammation so variable?

Authors:  Robert Terkeltaub
Journal:  BMC Med       Date:  2017-08-18       Impact factor: 8.775

7.  OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.

Authors:  Carlo Marchetti; Benjamin Swartzwelter; Fabia Gamboni; Charles P Neff; Katrin Richter; Tania Azam; Sonia Carta; Isak Tengesdal; Travis Nemkov; Angelo D'Alessandro; Curtis Henry; Gerald S Jones; Scott A Goodrich; Joseph P St Laurent; Terry M Jones; Curtis L Scribner; Robert B Barrow; Roy D Altman; Damaris B Skouras; Marco Gattorno; Veronika Grau; Sabina Janciauskiene; Anna Rubartelli; Leo A B Joosten; Charles A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205

8.  Arhalofenate acid inhibits monosodium urate crystal-induced inflammatory responses through activation of AMP-activated protein kinase (AMPK) signaling.

Authors:  Charles McWherter; Yun-Jung Choi; Ramon L Serrano; Sushil K Mahata; Robert Terkeltaub; Ru Liu-Bryan
Journal:  Arthritis Res Ther       Date:  2018-09-06       Impact factor: 5.156

9.  Triglycerides and Total Cholesterol Concentrations in Association with Hyperuricemia in Chinese Adults in Qingdao, China.

Authors:  Nan Cui; Jing Cui; Jianping Sun; Xinping Xu; Bilal Aslam; Lan Bai; Decheng Li; Di Wu; Zhongren Ma; Hai Gu; Zulqarnain Baloch
Journal:  Risk Manag Healthc Policy       Date:  2020-03-02

10.  Synthetic 4-Hydroxy Auxarconjugatin B, a Novel Autophagy Inducer, Attenuates Gouty Inflammation by Inhibiting the NLRP3 Inflammasome.

Authors:  Chih-Yu Hsieh; Lan-Hui Li; Yulin Lam; Zhanxiong Fang; Chin Heng Gan; Yerra Koteswara Rao; Hsiao-Wen Chiu; Wei-Ting Wong; Tz-Chuen Ju; Fang-Hsin Chen; Oleg V Chernikov; May-Lan Liu; Chung-Hua Hsu; Kuo-Feng Hua
Journal:  Cells       Date:  2020-01-23       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.